Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ZimVie Inc. - Common Stock (NQ: ZIMV )

14.04 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ZimVie Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
ZimVie's Earnings Outlook
Via Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
Via Benzinga
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie's Return On Capital Employed Insights
Via Benzinga
ZimVie (ZIMV) Q1 2023 Earnings Call Transcript
ZIMV earnings call for the period ending March 31, 2023. 
Via The Motley Fool
ZimVie: Q1 Earnings Insights
Via Benzinga
ZimVie (ZIMV) Q4 2022 Earnings Call Transcript
ZIMV earnings call for the period ending December 31, 2022. 
Via The Motley Fool
ZimVie to Present at the Stifel 2023 Jaws & Paws Conference
From ZimVie Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
Modernized 11,000 sq. ft. facility equipped for hands-on dental education and training underscores company’s commitment to lead the industry in advancing professional development of dental... 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
New offerings in ZimVie’s extensive portfolio of dental bone graft solutions enhance selection for customers and bolster cadence of recent product launches 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP 
From ZimVie Inc.
Via GlobeNewswire
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to... 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
The Tether™ device now deemed “medically necessary” for the treatment of pediatric scoliosis in additional patients covered by Highmark and BCBS North Dakota 
From ZimVie Inc.
Via GlobeNewswire
(ZIMV) - Analyzing ZimVie's Short Interest
ZimVie's (NASDAQ:ZIMV) short percent of float has fallen 84.44% since its last report. The company recently reported that it has 774 thousand shares sold short, which is 3.7% of all regular shares that... 
Via Benzinga
Why ZimVie Stock Was Plummeting on Thursday
The specialty healthcare devices and tech purveyor disappointed with both fourth-quarter figures and full-year guidance. 
Via The Motley Fool
Dow Jumps Over 300 Points; Best Buy Profit Beats Views
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Thursday. The Dow traded up 0.97% to 32,978.95 while the NASDAQ rose 0.59% to 11,446.55. The S&P... 
Via Benzinga
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Rises 100 Points; Macy's Posts Upbeat Earnings
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,764.50 while the NASDAQ fell 0.49% to 11,324.28. The S&P 500... 
Via Benzinga
Wall Street Mixed At Open; US Weekly Jobless Claims Decline
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 80 points on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 32,740.88 while the NASDAQ fell 0.58%... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules
Two innovations enhancing ZimVie’s digital dentistry platform 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®
Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine 
From ZimVie Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.